Persistence of human papillomavirus infection: keys to malignant progression

被引:230
作者
Bodily, Jason [1 ]
Laimins, Laimonis A. [1 ]
机构
[1] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
TYPE-16; E7; ONCOPROTEIN; LIFE-CYCLE; IN-VITRO; IMMUNE-RESPONSES; PRODUCTIVE CYCLE; NATURAL-HISTORY; MOUSE MODEL; PROTEIN; DIFFERENTIATION; EXPRESSION;
D O I
10.1016/j.tim.2010.10.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human papillomaviruses (HPVs) are the etiologic agents of cervical and other epithelial cancers. Persistence of infections by high-risk HPV types is the single greatest risk factor for malignant progression. Although prophylactic vaccines have been developed that target high-risk HPV types, there is a continuing need to understand better the virus-host interactions that underlie persistent benign infection and progression to cancer. In this review we summarize the molecular events that facilitate the differentiation-dependent HPV life cycle, how the life cycle is organized to facilitate virus persistence, and how the activities of HPV regulatory proteins result in malignancy.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 74 条
  • [1] Akers Aletha Y, 2007, Curr Probl Cancer, V31, P157, DOI 10.1016/j.currproblcancer.2007.01.001
  • [2] In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells
    Alcocer-Gonzalez, Juan Manuel
    Berumen, Jaime
    Tamez-Guerra, Reyes
    Bermudez-Morales, Victor
    Peralta-Zaragoza, Oscar
    Hernandez-Pando, Rogelio
    Moreno, Jose
    Gariglio, Patricio
    Madrid-Marina, Vicente
    [J]. VIRAL IMMUNOLOGY, 2006, 19 (03) : 481 - 491
  • [3] Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions
    Arany, I
    Tyring, SK
    [J]. SEXUALLY TRANSMITTED DISEASES, 1996, 23 (06) : 475 - 480
  • [4] Negative and positive regulation of HIF-1:: A complex network
    Bárdos, JI
    Ashcroft, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (02): : 107 - 120
  • [5] AMPLIFICATION OF HUMAN PAPILLOMAVIRUS GENOMES INVITRO IS DEPENDENT ON EPITHELIAL DIFFERENTIATION
    BEDELL, MA
    HUDSON, JB
    GOLUB, TR
    TURYK, ME
    HOSKEN, M
    WILBANKS, GD
    LAIMINS, LA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (05) : 2254 - 2260
  • [6] Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31
    Chang, YJE
    Laimins, LA
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (09) : 4174 - 4182
  • [7] Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior
    Chen, W.
    Li, F.
    Mead, L.
    White, H.
    Walker, J.
    Ingram, D. A.
    Roman, A.
    [J]. VIROLOGY, 2007, 367 (01) : 168 - 174
  • [8] Requirement for Estrogen Receptor α in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer
    Chung, Sang-Hyuk
    Wiedmeyer, Kerri
    Shai, Anny
    Korach, Kenneth S.
    Lambert, Paul F.
    [J]. CANCER RESEARCH, 2008, 68 (23) : 9928 - 9934
  • [9] The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism
    Clere, Nicolas
    Bermont, Laurent
    Fauconnet, Sylvie
    Lascombe, Isabelle
    Saunier, Maelle
    Vettoretti, Lucie
    Plissonnier, Marie-Laure
    Mougin, Christiane
    [J]. EXPERIMENTAL CELL RESEARCH, 2007, 313 (15) : 3239 - 3250
  • [10] p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
    Crum, Christopher P.
    McKeon, Frank. D.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 : 349 - 371